Back to Search

BIOA

BioAge Labs, Inc. Common Stock
Data: 2026-08-03
$10.78
Price
19.25%
Change
$25.96
52W High
$4.11
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Quick Stats
Aug 03, 2026

55.0

AI Score

HOLD

3.47

Volume Ratio

Aug 05, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

BIOA Stock Summary

Last updated Aug 03, 2026

BIOA is currently trading at $10.78, positioned below its 200-day moving average of $16.54, suggesting bearish momentum. The stock has a 52-week range of $4.11 to $25.955.

Technical Analysis: The 50-day moving average stands at $20.24, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 29.8, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.067, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BIOA at 55.0/100 with a HOLD recommendation.

BIOA (BioAge Labs, Inc. Common Stock) Indicators

Last updated Aug 03, 2026

Indicator Value
RSI(14) 29.8
CMF (20) -0.067
ROC (10) -51.703
ADX (14) 28.769
Indicator Value
MACD (12,26,9) -1.459
AROONOSC (14) -7.143
WILLAMS %R (14) -86.9
MFI (14) 43.292
BIOA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BIOA Price vs Max Options Open Interest
BIOA Max Change In Options Open Interest

BIOA Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BIOA Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BIOA Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BIOA Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

BioAge Labs, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

BIOA Moving Averages Analysis

BIOA (BioAge Labs, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 03, 2026

Days MA
10 19.79
20 21.49
30 22.21
50 20.24
100 19.02
200 16.54

BIOA Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 401.9 million
Earnings/Share ($) -2.4
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.5078
EPS Estimate Next Year ($) -2.4472
WallStreet Target Price ($) 39.88
Most Recent Quarter